BMRN
BioMarin Pharmaceutical Inc.
Latest News for BMRN
Cantor Fitzgerald analyst Olivia Brayer reiterated a Buy rating on BioMarin Pharmaceutical yesterday and set a price target of $80.00. The company’......
In a report released yesterday, Luca Issi from RBC Capital maintained a Hold rating on BioMarin Pharmaceutical, with a price target of $66.00. The ......
Biomarin Pharmaceutical Inc. ( ($BMRN) ) has released its Q3 earnings. Here is a breakdown of the information Biomarin Pharmaceutical Inc. presente......
Biomarin Pharmaceutical Inc. (($BMRN)) announced an update on their ongoing clinical study. BioMarin Pharmaceutical Inc. is conducting a clinical s......
Biomarin Pharmaceutical Inc. (($BMRN)) announced an update on their ongoing clinical study. BioMarin Pharmaceutical Inc. is conducting a Phase 3, o......
In a report released today, Gena Wang from Barclays maintained a Buy rating on BioMarin Pharmaceutical, with a price target of $86.00. The company’......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMRN | $54.69 | +4.2% | 3.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioMarin Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW